AMANTADINE OR METHYLPHENIDATE? COMPARISON BETWEEN THE EFFECTIVENESS AMONG CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

KAZEMI M.R.; MOHAMMADI M.R.; AKHONDZADEH SH.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Ebnesina Year:2011 | Volume:14 | Issue:3 (41) Page(s): 10-16

Download Full-Text

Persian Verion

View:

1,444

Download:

Cites:

Information Journal Paper

Title

AMANTADINE OR METHYLPHENIDATE? COMPARISON BETWEEN THE EFFECTIVENESS AMONG CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER

Author(s)

KAZEMI M.R. | MOHAMMADI M.R. | AKHONDZADEH SH. | Issue Writer Certificate

Keywords

AMANTADINEQ2

METHYLPHENIDATEQ2

ATTENTION-DEFICIT/ HYPERACTIVITY DISORDERQ2

Abstract

Background: The aim of the present study was to further evaluate, under double blind and controlled conditions, the efficacy of AMANTADINE for attention-deficit/hyperactivity disorder (ADHD) in children and adolescents as compared to METHYLPHENIDATE.Materials and methods: this was a 6-week randomized clinical trial. Forty patients (28 boys and 12 girls) with a DSM-IV-TR diagnosis of ADHD were the study population of this trial. All study subjects were randomly assigned to receive the treatment using capsule of AMANTADINE at a dose of 100–150 mg/day depending on weight (100 mg/day for<30 kg and 150 mg/day for>30 kg) or METHYLPHENIDATE at a dose of 20–30 mg/day for a 6- week double blind, randomized clinical trial. The principal measure of outcome was the Teacher and Parent Attention Deficit/Hyperactivity Disorder Rating Scale-IV.Results: No significant differences were observed between the two groups on the Parent and Teacher Rating Scale scores (df=1, F=0.02, p=0.86 and df=1, F=0.01, p=0.89, respectively). Side effects of decreased appetite and restlessness were observed more frequently in the METHYLPHENIDATE group.Conclusion: The results of this study indicate that AMANTADINE significantly improved symptoms of ADHD and was well tolerated and it may be beneficial in the treatment of children with ADHD. Nevertheless, the present results do not constitute proof of efficacy.

Cites

No record.

References

No record.

Cite

APA: Copy

KAZEMI, M.R., MOHAMMADI, M.R., & AKHONDZADEH, SH.. (2011). AMANTADINE OR METHYLPHENIDATE? COMPARISON BETWEEN THE EFFECTIVENESS AMONG CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER. EBNESINA, 14(3 (41)), 10-16. SID. https://sid.ir/paper/228666/en

Vancouver: Copy

KAZEMI M.R., MOHAMMADI M.R., AKHONDZADEH SH.. AMANTADINE OR METHYLPHENIDATE? COMPARISON BETWEEN THE EFFECTIVENESS AMONG CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER. EBNESINA[Internet]. 2011;14(3 (41)):10-16. Available from: https://sid.ir/paper/228666/en

IEEE: Copy

M.R. KAZEMI, M.R. MOHAMMADI, and SH. AKHONDZADEH, “AMANTADINE OR METHYLPHENIDATE? COMPARISON BETWEEN THE EFFECTIVENESS AMONG CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER,” EBNESINA, vol. 14, no. 3 (41), pp. 10–16, 2011, [Online]. Available: https://sid.ir/paper/228666/en

Related Journal Papers